Stock Events

Stock Events

Photocure ASA 

$7.07
13
+$0.07+1% Monday 20:00

Statistics

Day High
7.07
Day Low
7.07
52W High
7.07
52W Low
4.32
Volume
100
Avg. Volume
-
Mkt Cap
191.75M
P/E Ratio
20.79
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jun 13
$0.34
Dec 9
$0.7
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
Next
-0.03
-0.01
0
0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-0.71%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
86.92MRevenue
-621,316.04Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PHCUF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbvie
ABBV
Mkt Cap356.49B
AbbVie competes in the bladder cancer space with treatments that could be seen as alternatives to Photocure's diagnostic solutions.
Roche
RHHBY
Mkt Cap329.06B
Roche Holding AG offers a range of oncology treatments, including diagnostics and therapeutics that could compete with Photocure's bladder cancer detection and treatment products.
Bristol-Myers Squibb
BMY
Mkt Cap114.68B
Bristol-Myers Squibb has a portfolio of oncology products that could serve as alternatives to Photocure's offerings, particularly in the bladder cancer segment.
Merck
MRK
Mkt Cap275.09B
Merck & Co., Inc. provides a variety of cancer treatments, including immunotherapies that could compete with Photocure's bladder cancer solutions.
Pfizer
PFE
Mkt Cap146.36B
Pfizer Inc. has a broad oncology portfolio, including treatments for bladder cancer that could compete with Photocure's products.
Astrazeneca
AZN
Mkt Cap283.47B
AstraZeneca PLC has a strong presence in the oncology market, including treatments that could compete with Photocure's bladder cancer diagnostics and therapeutics.
Novartis
NVS
Mkt Cap278.64B
Novartis AG offers a wide range of cancer treatments, including therapies for bladder cancer that could be seen as competitive to Photocure's products.
Johnson & Johnson
JNJ
Mkt Cap532.77B
Johnson & Johnson, through its Janssen Pharmaceuticals division, develops oncology treatments that could compete with Photocure's bladder cancer solutions.
GSK
GSK
Mkt Cap101.2B
GlaxoSmithKline plc has a portfolio of oncology products, including treatments for bladder cancer that could compete with Photocure's offerings.
Sanofi
SNY
Mkt Cap103.76B
Sanofi offers oncology treatments, including those for bladder cancer, that could serve as alternatives to Photocure's diagnostic and therapeutic products.

About

There is no Profile data available for PHS.SG.
Show more...
CEO
Mr. Daniel Schneider
Employees
99
Country
United States
ISIN
NO0010000045

Listings

ST
SE
PHOO.ST
STU
DE
PHS.STU
LSE
GB
0IMT.LSE
F
DE
PHS.F

0 Comments

Share your thoughts

FAQ

What is Photocure ASA stock price today?▼
The current price of PHCUF is $7.07 USD — it has increased by +1% in the past 24 hours. Watch Photocure ASA stock price performance more closely on the chart.
What is Photocure ASA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Photocure ASA stocks are traded under the ticker PHCUF.
What is Photocure ASA market cap?▼
Today Photocure ASA has the market capitalization of 191.75M
When is the next Photocure ASA earnings date?▼
Photocure ASA is going to release the next earnings report on July 29, 2026.
What is Photocure ASA revenue for the last year?▼
Photocure ASA revenue for the last year amounts to 86.92M USD.
What is Photocure ASA net income for the last year?▼
PHCUF net income for the last year is -621,316.04 USD.
Does Photocure ASA pay dividends?▼
Yes, PHCUF dividends are paid en. The last dividend per share was 0.34 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Photocure ASA have?▼
As of May 16, 2026, the company has 99 employees.
In which sector is Photocure ASA located?▼
Photocure ASA operates in the Health & Wellness sector.
When did Photocure ASA complete a stock split?▼
Photocure ASA has not had any recent stock splits.
Where is Photocure ASA headquartered?▼
Photocure ASA is headquartered in Oslo, United States.